Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is an open-labeled study of Aripiprazole, testing its efficacy in the treatment of mania
in children and adolescents with Bipolar I, Bipolar II and Bipolar Spectrum Disorder over 8
weeks. This is an exploratory, pilot study, seeking to determine whether Aripiprazole is
efficacious and well tolerated in the treatment of youth with pediatric bipolar and bipolar
spectrum disorder. The study results will be used to generate hypotheses for a larger
randomized controlled clinical trial with explicit hypotheses and sufficient statistical
power.